Fennec Pharmaceuticals Ownership | Who Owns Fennec Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Fennec Pharmaceuticals Ownership Summary


Fennec Pharmaceuticals is owned by 53.10% institutional investors, 16.16% insiders, and 30.74% retail investors. Southpoint capital advisors lp is the largest institutional shareholder, holding 15.08% of FENC shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.20% of its assets in Fennec Pharmaceuticals shares.

FENC Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockFennec Pharmaceuticals53.10%16.16%30.74%
SectorHealthcare Stocks 47.06%8.01%44.93%
IndustryBiotech Stocks 44.97%7.82%47.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Southpoint capital advisors lp4.08M15.08%$24.91M
Sonic gp2.41M8.90%$14.71M
Dg capital management1.63M6.04%$9.99M
Solas capital management1.34M4.95%$8.19M
Blackrock1.19M4.39%$7.25M
Vanguard group1.03M3.80%$6.27M
Harbert fund advisors466.87K1.73%$2.85M
State street321.21K1.19%$1.96M
Geode capital management301.58K1.12%$1.84M
Gendell jeffrey l283.37K1.05%$1.73M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sonic gp2.41M30.37%$14.71M
Solas capital management1.34M4.48%$8.19M
Dg capital management1.63M3.85%$9.99M
Harbert fund advisors466.87K2.03%$2.85M
Lion point capital, lp170.00K1.89%$1.04M
Southpoint capital advisors lp4.08M0.62%$24.91M
Hartford financial management48.85K0.06%$298.46K
Gendell jeffrey l283.37K0.06%$1.73M
Wexford capital lp26.41K0.04%$161.39K
Sherbrooke park advisers28.37K0.03%$173.34K

Top Buyers

HolderShares% AssetsChange
Blackrock1.19M0.00%259.78K
Solas capital management1.34M4.48%229.77K
Dg capital management1.63M3.85%123.15K
Geode capital management301.58K0.00%81.82K
Winton group67.00K0.03%67.00K

Top Sellers

HolderShares% AssetsChange
Aigh capital management---570.33K
Essex investment management---144.22K
Renaissance---139.90K
Legato capital management---57.12K
683 capital management---48.11K

New Positions

HolderShares% AssetsChangeValue
Winton group67.00K0.03%67.00K$409.40K
Verition fund management33.74K0.00%33.74K$206.14K
Sherbrooke park advisers28.37K0.03%28.37K$173.34K
State of wisconsin investment board13.03K0.00%13.03K$79.64K
Corebridge financial12.61K0.00%12.61K$77.05K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-3.00
Toronto dominion bank-25.00
Cornerstone planning group-66.00
Citadel advisors-100.00
Point72 (difc)-256.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202462-7.46%14,360,529-0.88%531.82%4113.89%11-42.11%
Mar 31, 20246715.52%14,487,913-3.48%531.68%3624.14%1935.71%
Dec 31, 202358-1.69%15,010,9684.85%561.94%2945.00%14-17.65%
Sep 30, 202359-1.67%14,316,4291.60%541.92%20-45.95%1741.67%
Jun 30, 2023603.45%14,091,3018.06%532.20%37-2.63%1271.43%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv876.21K3.20%-
iShares Russell 2000 ETF559.37K2.04%-1.26K
Fidelity Small Cap Index241.02K0.88%-4.65K
iShares Russell 2000 Value ETF165.51K0.60%-
State St Russell Sm/Mid Cp® Indx NL Cl C122.70K0.45%-
Vanguard Russell 2000 ETF107.20K0.39%-680.00
State St Russell Sm Cap® Indx SL Cl I69.00K0.25%-
NT R2000 Index Fund - NL57.45K0.21%16.89K
Schwab Small Cap Index55.45K0.20%-
iShares Micro-Cap ETF53.29K0.19%-

Recent Insider Transactions


DateNameRoleActivityValue
Nov 04, 2024Raykov Rosty-Sell$10.48K
Oct 08, 2024RALLIS CHRIS A-Sell$6.37K
Oct 01, 2024Raykov Rosty-Sell$12.01K
Sep 04, 2024Raykov Rosty-Sell$13.42K
Aug 01, 2024Raykov Rosty CHIEF EXECUTIVE OFFICERSell$15.21K

Insider Transactions Trends


DateBuySell
2025 Q3--
2024 Q4-1
2024 Q3-4
2024 Q2218
2024 Q1-5

FENC Ownership FAQ


Who Owns Fennec Pharmaceuticals?

Fennec Pharmaceuticals shareholders are primarily institutional investors at 53.10%, followed by 16.16% insiders and 30.74% retail investors. The average institutional ownership in Fennec Pharmaceuticals's industry, Biotech Stocks , is 44.97%, which Fennec Pharmaceuticals exceeds.

Who owns the most shares of Fennec Pharmaceuticals?

Fennec Pharmaceuticals’s largest shareholders are Southpoint capital advisors lp (4.08M shares, 15.08%), Sonic gp (2.41M shares, 8.90%), and Dg capital management (1.63M shares, 6.04%). Together, they hold 30.02% of Fennec Pharmaceuticals’s total shares outstanding.

Does Blackrock own Fennec Pharmaceuticals?

Yes, BlackRock owns 4.39% of Fennec Pharmaceuticals, totaling 1.19M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 7.25M$. In the last quarter, BlackRock increased its holdings by 259.78K shares, a 28.01% change.

Who is Fennec Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Sonic gp is Fennec Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 30.37% of its assets in 2.41M Fennec Pharmaceuticals shares, valued at 14.71M$.

Who is the top mutual fund holder of Fennec Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Fennec Pharmaceuticals shares, with 3.20% of its total shares outstanding invested in 876.21K Fennec Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools